evidence: July 20 — Diagnostic Delays From COVID-19 May Increase Cancer-Related Deaths The next several years could bear witness to thousands of additional deaths from cancer that could have been prevented through routine diagnostic care that was delayed because of the COVID-19 pandemic. Notably, delays in referrals and screenings for breast, colorectal, esophageal, and lung cancers were indicated in a pair of studies published in The Lancet Oncology to potentially lead to almost 10% (n = 3291-3621) more deaths in England over the next 5 years. [...] In just 4 days, there’s been a 3.2% uptick in COVID-19–related deaths, to 170,434, giving the disease a No. 3 ranking behind heart disease in the top spot and cancer at No. 2. Deaths now exceed 1000 per day and nationwide cases exceed 5.4 million. Testing has dropped off by an average 68,000 per day, despite death being 8 times more likely in the United States vs in Europe.